Syncom Formulations Files Compliance Certificate for Q4 FY26
Syncom Formulations (India) Limited submitted a compliance certificate for Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the quarter ended March 31, 2026. It confirms the processing of dematerialized securities and updates to the register of members.
This is a standard regulatory filing required by SEBI and does not involve any new business developments, financial results, or strategic changes that would directly impact the company's operations or stock performance.
The announcement is a routine compliance filing and does not contain any new financial information or significant corporate actions that would impact the company's outlook.
Syncom Formulations (India) Limited has submitted a certificate for compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate, received from their Registrar and Share Transfer Agent, M/s Ankit Consultancy Pvt. Ltd., pertains to the quarter ended March 31, 2026.
The certificate confirms that securities received from depository participants for dematerialization during the specified quarter were processed, and the corresponding certificates were either accepted or rejected by the depositories. It also verifies that the securities are listed on the stock exchanges where the company's shares are already traded. Furthermore, the Registrar and Share Transfer Agent confirmed that the security certificates received for dematerialization were duly verified, mutilated, and cancelled, with the depositories' names substituted in the register of members as the registered owners within the stipulated 15-day period.
The company has submitted this document for record and necessary action by the stock exchanges, BSE Limited and the National Stock Exchange of India Limited.
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.